Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction

Yun-Peng Peng, Jing-Jing Zhang, Wen-biao Liang

  • 1Department of General Surgery, The first Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, People's Republic of China. miaoyi@njmu.edu.cn.

BMC Cancer
|October 3, 2014
PubMed
Abstract

Insights

Pancreatic cancer cells impair natural killer (NK) cell anti-tumor functions by increasing MMP-9 and IDO. Restoring NK cell activity may improve pancreatic cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Natural killer (NK) cells are crucial for non-specific immune responses in various cancers, including pancreatic cancer.
  • NK cell anti-tumor activity diminishes as pancreatic cancer progresses, contributing to tumor immune escape.
  • The precise mechanisms of NK cell regulation in pancreatic cancer remain incompletely understood.

Purpose of the Study:

  • To investigate the factors contributing to NK cell dysfunction in pancreatic cancer.
  • To elucidate the regulatory pathways involved in NK cell-mediated tumor immune escape.

Main Methods:

  • In vitro co-culture of NK cells with normal pancreatic ductal cells and pancreatic cancer cell lines.
  • Flow cytometry to assess NK cell surface receptors, cytotoxic granules, apoptosis, and cytotoxicity.
  • ELISA for cytokine analysis and quantitative RT-PCR for MMP-9, IDO, and COX-2 expression.
  • Statistical analysis using independent t-tests.

Main Results:

  • Pancreatic cancer cells significantly downregulated NK cell function compared to normal cells.
  • Observed reductions in activating receptors, cytotoxic granules, cytokine secretion (TNF-α, IFN-γ), and cytotoxicity.
  • MMP-9 and IDO expression in cancer cells were implicated in NK cell dysfunction and immune evasion.
  • Blockade of MMP-9 (TIMP-1) and IDO (1-MT) partially restored NK cell function.

Conclusions:

  • Elevated MMP-9 and IDO induced by pancreatic cancer cells mediate NK cell dysfunction.
  • These findings suggest potential therapeutic targets for enhancing NK cell-based immunotherapy in pancreatic cancer.